Linagliptin NOBEL 5mg

Linagliptin NOBEL 5mg is a medicine authorised by Swissmedic under authorisation number 70123. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 November 2025 and the authorisation is limited until 24 November 2030. ATC code A10BH05 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 70123
  • ATC A10BH05
  • Synthetic medicines
Authorisation data
Authorisation number70123
NameLinagliptin NOBEL 5mg
Full nameLinagliptin NOBEL 5mg, Filmtabletten
Authorisation holderNOBEL Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA10BH05
First authorisation25 November 2025
Authorisation validity24 November 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Linagliptin NOBEL 5mg, FilmtablettenB25 November 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)A10BH0507.06.2.B
290Tablette(n)A10BH0507.06.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Linagliptin NOBEL 5mg authorised in Switzerland?

Yes. Linagliptin NOBEL 5mg is authorised by Swissmedic under authorisation number 70123, data as of 01 September 2026. The authorisation is limited until 24 November 2030.

Which dispensing category does Linagliptin NOBEL 5mg have?

Linagliptin NOBEL 5mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Linagliptin NOBEL 5mg?

The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com